COVID-19 Impact

You may see some delays in posting new content due to COVID-19. If you have any questions, please submit a message to PSNet Support.

PSNet: Patient Safety Network
Journal Article

Polypharmacy in the elderly- when good drugs lead to bad outcomes: a teachable moment.

Carroll C, Hassanin A. JAMA internal medicine. 2017;177:871.

Geriatric patients are particularly vulnerable to adverse drug events due to comorbidities, complicated care plans, and polypharmacy. This commentary describes how using STOPP criteria and performing indication mapping can help reduce polypharmacy and improve patient safety.